RDHL
Redhill Biopharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RDHL fundamentals
Redhill Biopharma (RDHL) released its earnings on Jan 30, 2024: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Jan 30, 2024
EPS
Revenue
Revenue & Expenses
RDHL has released its 2023 Q2 earnings report, with revenue of 1.80M, reflecting a YoY change of -90.21%, and net profit of 761.00K, showing a YoY change of 106.50%. The Sankey diagram below clearly presents RDHL's revenue sources and cost distribution.
Key Indicators
Redhill Biopharma (RDHL) key financial stats and ratios, covering profitability, financial health, and leverage.
Redhill Biopharma (RDHL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Redhill Biopharma (RDHL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Redhill Biopharma (RDHL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Redhill Biopharma (RDHL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Redhill Biopharma (RDHL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Redhill Biopharma do and what are its main business segments?What is Redhill Biopharma’s gross profit margin?What is Redhill Biopharma’s latest dividend and current dividend yield?What is the market’s earnings forecast for Redhill Biopharma next quarter?Did Redhill Biopharma beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Redhill Biopharma year over year?What were the key takeaways from Redhill Biopharma’s earnings call?How were Redhill Biopharma’s latest financial results overall?